サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1791723

更年期障害の世界市場

Menopause

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
更年期障害の世界市場
出版日: 2025年08月15日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

更年期障害の世界市場は2030年までに223億米ドルに達する見込み

2024年に173億米ドルと推定される更年期障害の世界市場は、分析期間2024-2030年にCAGR 4.3%で成長し、2030年には223億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである栄養補助食品は、CAGR 5.0%を記録し、分析期間終了時には156億米ドルに達すると予想されます。OTC医薬品セグメントの成長率は、分析期間中CAGR 2.8%と推定されます。

米国市場は47億米ドルと推定、中国はCAGR 8.0％で成長予測

米国の更年期障害市場は2024年に47億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに46億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.7%と3.4%と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界の更年期障害ケア市場- 主要動向と市場促進要因まとめ

更年期障害ケアはなぜヘルスケア業界で注目されているのか？

更年期障害ケアは、女性の健康、ホルモンバランス、閉経後の健康に対する意識が新たな高みに達するにつれ、大きな変革期を迎えています。更年期障害は、月経の終わりを告げる生物学的な自然な移行であり、ほてり、寝汗、気分の落ち込み、骨粗しょう症、心血管リスク、代謝の変化など、身体的・精神的な症状を幅広く伴う。世界中で何百万人もの女性が影響を受けているにもかかわらず、更年期障害ケアは、歴史的にヘルスケア業界ではあまり議論されず、資金も不足していました。しかし、女性の健康に対する考え方の変化、アドボカシーの高まり、ホルモン療法やウェルネス・ソリューションの技術的進歩により、更年期障害に焦点を当てた治療やホリスティック・ケア戦略がブームとなっています。製薬会社、デジタルヘルスプラットフォーム、ウェルネスブランドは現在、ホルモン補充療法（HRT）、非ホルモンサプリメント、ライフスタイル介入、AI主導の更年期障害追跡アプリなど、更年期障害に特化したソリューションを優先しています。平均寿命の延長と積極的な加齢動向により、より多くの女性がエビデンスに基づく更年期障害ケアソリューションを求めており、ホルモン療法イノベーション、遠隔健康相談更年期障害、パーソナライズされたウェルネスプログラムの成長に拍車をかけています。

更年期障害ケアの革新は症状管理をどのように改善しているか？

更年期障害ケア市場は、ホルモン療法、植物由来の代替医療、デジタルヘルスソリューション、AIを活用した診断の進歩により、急速に進化しています。最も重要な開発の一つは、バイオアイデンティカルホルモンや経皮エストロゲンパッチなど、ホルモン補充療法（HRT）の改良です。栄養補助食品、植物性エストロゲンをベースとしたサプリメント、アダプトジェニック・ハーブなど、ホルモン以外の代替品の台頭は、更年期障害の症状に対する自然療法を求める女性に対応しています。AIを駆使した更年期障害健康アプリ、体温追跡のためのウェアラブルデバイス、機械学習ベースのホルモン分析は、症状のパターン、ライフスタイルの調整、治療の推奨に関するリアルタイムの洞察で女性に力を与えています。さらに、テレヘルスプラットフォームやバーチャル更年期障害クリニックは、女性が内分泌学者、婦人科医、栄養士に遠隔で相談できるようにし、専門的ケアへのアクセスに革命をもたらしています。個別化されたスキンケア、膣の健康ソリューション、骨密度維持サプリメントの開発も、従来の治療法を超えて更年期障害ケアを拡大し、老化関連のウェルネスのための包括的なエコシステムを作り出しています。

多様な消費者層で更年期障害ケアの需要が増加しているのはなぜか？

更年期障害ケアソリューションへの需要は、認知度の向上、高齢化、更年期障害に関する議論の非宗教化により、世界的に急増しています。40代、50代、それ以降の女性は、積極的な健康管理を優先するようになり、サプリメント、ウェルネス・コーチング、統合的な更年期障害治療の採用が増加しています。更年期の健康に取り組む企業のウェルネス・プログラムが職場で拡大していることも、市場の成長を後押ししています。雇用主は、更年期障害に関連する課題を経験している女性従業員をサポートすることの重要性を認識しているからです。さらに、植物由来、無農薬、ホリスティックな更年期障害製品に対する需要の高まりは、クリーンラベルの健康ソリューションを求める広範な動向を反映しています。ソーシャルメディア、女性の健康インフルエンサー、更年期障害擁護団体の影響力は、利用可能な治療オプションについて女性をさらに教育し、タブーを破り、中年期の健康と加齢に関するオープンな議論を促しています。

世界の更年期障害ケア市場の成長の原動力は？

更年期障害ケア市場の成長は、ヘルスケア投資の増加、個別化治療に対する需要の増加、ホルモン健康におけるAI主導型診断の統合によってもたらされます。デジタルヘルスプラットフォーム、ウェアラブル更年期障害トラッカー、遠隔健康相談の拡大により、更年期障害管理はよりアクセスしやすく、データ主導型になっています。バイオアイデンティカル・ホルモン、植物由来の更年期障害サプリメント、腸の健康に焦点を当てた治療が利用可能になりつつあり、多様な消費者の嗜好に対応しています。ホルモン療法の安全性に関する医学的調査の活発化、消費者の意識の高まり、更年期障害に焦点を当てたウェルネスブランドの台頭により、世界の更年期障害ケア市場は、革新的な治療法、デジタルヘルスの拡大、ホリスティックエイジングソリューションに支えられ、持続的な成長を遂げようとしています。

セグメント

治療（栄養補助食品、OTC医薬品）

調査対象企業の例

  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan（an AbbVie company）
  • Amneal Pharmaceuticals LLC
  • Avion Pharmaceuticals, LLC
  • Bayer AG
  • Cipla Inc.
  • Duchesnay USA
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Teva Pharmaceutical Industries Ltd.
  • Theramex
  • TherapeuticsMD, Inc.
  • Viatris Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32089

Global Menopause Market to Reach US$22.3 Billion by 2030

The global market for Menopause estimated at US$17.3 Billion in the year 2024, is expected to reach US$22.3 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Dietary Supplements, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$15.6 Billion by the end of the analysis period. Growth in the OTC Pharma Products segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.7 Billion While China is Forecast to Grow at 8.0% CAGR

The Menopause market in the U.S. is estimated at US$4.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.6 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Menopause Care Market - Key Trends & Growth Drivers Summarized

Why Is Menopause Care Gaining More Attention in the Healthcare Industry?

Menopause care is undergoing a major transformation, as awareness about women’s health, hormonal balance, and post-menopausal wellness reaches new heights. Menopause, a natural biological transition that marks the end of menstruation, is associated with a wide range of physical and emotional symptoms, including hot flashes, night sweats, mood swings, osteoporosis, cardiovascular risks, and metabolic changes. Despite affecting millions of women worldwide, menopause care was historically under-discussed and underfunded in the healthcare industry. However, changing attitudes toward women's health, increased advocacy, and technological advancements in hormone therapy and wellness solutions have led to a boom in menopause-focused treatments and holistic care strategies. Pharmaceutical companies, digital health platforms, and wellness brands are now prioritizing menopause-specific solutions, including hormone replacement therapy (HRT), non-hormonal supplements, lifestyle interventions, and AI-driven menopause tracking apps. With longer life expectancy and proactive aging trends, more women are seeking evidence-based menopause care solutions, fueling growth in hormone therapy innovations, telehealth menopause consultations, and personalized wellness programs.

How Are Innovations in Menopause Care Improving Symptom Management?

The menopause care market is evolving rapidly, thanks to advances in hormone therapy, plant-based alternatives, digital health solutions, and AI-powered diagnostics. One of the most significant developments is the refinement of hormone replacement therapy (HRT), including bioidentical hormones and transdermal estrogen patches, which offer safer, more personalized treatments with reduced side effects. The rise of non-hormonal alternatives, such as nutraceuticals, phytoestrogen-based supplements, and adaptogenic herbs, is catering to women seeking natural remedies for menopause symptoms. AI-driven menopause health apps, wearable devices for temperature tracking, and machine-learning-based hormonal analytics are empowering women with real-time insights into symptom patterns, lifestyle adjustments, and treatment recommendations. Additionally, telehealth platforms and virtual menopause clinics are revolutionizing access to specialized care, allowing women to consult endocrinologists, gynecologists, and nutritionists remotely. The development of personalized skincare, vaginal health solutions, and bone density preservation supplements is also expanding menopause care beyond traditional treatment methods, creating a comprehensive ecosystem for aging-related wellness.

Why Is Demand for Menopause Care Increasing Across Diverse Consumer Segments?

The demand for menopause care solutions is surging globally, driven by increased awareness, aging populations, and the destigmatization of menopause discussions. Women in their 40s, 50s, and beyond are now prioritizing proactive health management, leading to increased adoption of supplements, wellness coaching, and integrative menopause treatments. The expansion of corporate wellness programs addressing menopausal health in the workplace is also fueling market growth, as employers recognize the importance of supporting female employees experiencing menopause-related challenges. Additionally, the rising demand for plant-based, cruelty-free, and holistic menopause products reflects a broader trend toward clean-label health solutions. The influence of social media, women’s health influencers, and menopause advocacy groups is further educating women about available treatment options, breaking taboos, and encouraging open discussions about midlife health and aging.

What Is Driving the Growth of the Global Menopause Care Market?

The growth in the menopause care market is driven by rising healthcare investments, increasing demand for personalized treatments, and the integration of AI-driven diagnostics in hormonal health. The expansion of digital health platforms, wearable menopause trackers, and telehealth consultations is making menopause management more accessible and data-driven. The increasing availability of bioidentical hormones, plant-based menopause supplements, and gut-health-focused treatments is catering to diverse consumer preferences. With greater medical research on hormone therapy safety, growing consumer awareness, and the rise of menopause-focused wellness brands, the global menopause care market is positioned for sustained growth, supported by innovative therapies, digital health expansion, and holistic aging solutions.

SCOPE OF STUDY:

The report analyzes the Menopause market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Dietary Supplements, OTC Pharma Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan (an AbbVie company)
  • Amneal Pharmaceuticals LLC
  • Avion Pharmaceuticals, LLC
  • Bayer AG
  • Cipla Inc.
  • Duchesnay USA
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Procter & Gamble Co.
  • Teva Pharmaceutical Industries Ltd.
  • Theramex
  • TherapeuticsMD, Inc.
  • Viatris Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Menopause - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness and Openness Around Menopause Health Throws the Spotlight on Women's Midlife Wellness Market
    • Shifting Demographics and Aging Population Spur Demand for Menopause-Focused Therapies and Products
    • Growing Popularity of Holistic and Natural Remedies Strengthens Business Case for Botanical-Based Menopause Solutions
    • Surge in Femtech Innovations Drives Adoption of Digital Menopause Management Tools
    • Increasing Focus on Personalized Healthcare Expands Addressable Market Opportunity for Customized Menopause Treatments
    • Celebrity and Influencer Advocacy Accelerates Demand for Menopause-Friendly Lifestyle Products
    • Integration of AI in Hormonal Health Diagnostics Drives Precision in Menopause Care Solutions
    • Changing Workplace Policies on Women's Health Drives Inclusion of Menopause Benefits in Corporate Wellness Programs
    • Regulatory Push for Recognition of Menopause as a Health Priority Strengthens Funding and Research Opportunities
    • Rapid Proliferation of Direct-to-Consumer (DTC) Brands Spurs Growth of E-commerce Channels for Menopause Products
    • Emerging Clinical Evidence Around Non-Hormonal Alternatives Propels Market for Non-HRT (Hormone Replacement Therapy) Solutions
    • Heightened Investment Activity in Women's Health Tech Ecosystem Expands Innovation Pipeline for Menopause Startups
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Menopause Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dietary Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dietary Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for OTC Pharma Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for OTC Pharma Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for OTC Pharma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • JAPAN
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • CHINA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • EUROPE
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Menopause by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Menopause by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • FRANCE
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • GERMANY
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Spain 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Russia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Menopause by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Australia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • INDIA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: India 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: South Korea 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Menopause by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Menopause by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Latin America 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Argentina 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Mexico 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Menopause by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Menopause by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Middle East 15-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Iran 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Israel 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UAE 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030
  • AFRICA
    • Menopause Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Menopause by Treatment - Dietary Supplements and OTC Pharma Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Menopause by Treatment - Dietary Supplements and OTC Pharma Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Africa 15-Year Perspective for Menopause by Treatment - Percentage Breakdown of Value Sales for Dietary Supplements and OTC Pharma Products for the Years 2015, 2025 & 2030

IV. COMPETITION